Filing Details
- Accession Number:
- 0001179110-14-013684
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-09-04 16:03:27
- Reporting Period:
- 2014-09-02
- Filing Date:
- 2014-09-04
- Accepted Time:
- 2014-09-04 16:03:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1140098 | Advanced Cell Technology Inc. | ACTCD | Pharmaceutical Preparations (2834) | 870656515 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1317093 | Robert Lanza | 33 Locke Dr. C/O Advanced Cell Technology Inc. Marlborough MA 01752 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-09-02 | 10,000 | $8.12 | 214,439 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-09-02 | 5,000 | $9.01 | 209,439 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-09-03 | 10,000 | $9.00 | 199,439 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 Plan
- Shares and stock price represented were impacted by a 1 for 100 reverse stock split which occurred on August 28, 2014
- This transaction was executed in multiple trades at prices ranging from $8.00 to $8.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the full information regarding the number of shares and prices at which each transaction was effected.
Billionaire Hedge Funds
